NDC 0172-5240
Anagrelide Hydrochloride
Anagrelide Hydrochloride
Anagrelide Hydrochloride is a Oral Capsule in the Human Prescription Drug category.  It is labeled and distributed by Teva Pharmaceuticals Usa, Inc.. The primary component is Anagrelide Hydrochloride.
| Product ID | 0172-5240_1840a429-9e76-4ef9-91ae-293c6e9310b6 | 
| NDC | 0172-5240 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Anagrelide Hydrochloride | 
| Generic Name | Anagrelide Hydrochloride | 
| Dosage Form | Capsule | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2005-04-18 | 
| Marketing Category | ANDA / ANDA | 
| Application Number | ANDA076468 | 
| Labeler Name | Teva Pharmaceuticals USA, Inc. | 
| Substance Name | ANAGRELIDE HYDROCHLORIDE | 
| Active Ingredient Strength | 1 mg/1 | 
| Pharm Classes | Decreased Platelet Production [PE],Platelet-reducing Agent [EPC],Phosphodiesterase 3 Inhibitors [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2022-12-31 |